Venter discusses the future of genomics

03/12/2013 | Medscape (free registration)

The next step in the genomics revolution is to incorporate genomics into drug testing and development, says genomics pioneer J. Craig Venter. As genome sequencing has gotten faster and cheaper, it has also gotten less accurate, and a diploid genome map is necessary to pinpoint the genetics associated with a given disease, Venter said. His new institute on the University of California, San Diego, campus will focus on synthetic and environmental genomics research as well as the relationship between microbiomes and disease.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA
Senior Compliance Analyst
ACell, Inc.
Columbia, MD
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA